Nachrichten zur Biogen Aktie

Big Take: What Biogen ALS Drug Approval Could Mean for Patients

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

1 Green Flag and 1 Red Flag for Biogen

Biogen beat the bear market this year....…

New Alzheimers Drug Could Be Priced Up to $20,000 a Year: Group

The FDA next month will consider approving the drug Lecanemab from Biogen and Eisai....…

EISAI INITIATES BLA SUBMISSION OF DATA FOR LECANEMAB IN CHINA

TOKYO and CAMBRIDGE, Mass., Dec. 22, 2022 /PRNewswire/ -- Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, "Eisai") and Biogen…

Biogen Inc. (BIIB) Stock Sinks As Market Gains: What You Should Know

Biogen Inc. (BIIB) closed at $286.86 in the latest trading session, marking a -0.23% move from the prior day....…

Biogen Signs Agreement With Genentech For Royalties On Glofitamab

WESTON (dpa-AFX) - Biogen Inc. (BIIB) Monday announced that it has reached an agreement with Genentech of the Roche Group…

Roche: Genentech und Biogen vereinbaren Vermarktung von Krebsmittel Glofitamab

Pharma - Die Roche-Tochter Genentech und das US-Biotechunternehmen Biogen haben die künftigen Vermarktungsdetails für die Krebstherapie Glofitamab ausgehandelt....…

Biogen Reaches Agreement with Genentech to Receive Royalties on the Potential Commercialization of a Late-Stage Bispecific Antibody as Part of Anti-CD20 Collaboration

CAMBRIDGE, Mass., Dec. 19, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced that it has reached an…

Better Bear Market Buy: Vertex Pharmaceuticals vs. Biogen Stock

Both stocks are heading for double-digit gains this year....…

Biogen Inc. (BIIB) Stock Moves -1.94%: What You Should Know

Biogen Inc. (BIIB) closed at $283.44 in the latest trading session, marking a -1.94% move from the prior day....…

Biogen Inc. (BIIB) Dips More Than Broader Markets: What You Should Know

Biogen Inc. (BIIB) closed the most recent trading day at $285.37, moving -1.29% from the previous trading session....…

Biogen: FDA Accepts BLA For BIIB800, Biosimilar Candidate Referencing ACTEMRA

WESTON (dpa-AFX) - The U.S. Food and Drug Administration has accepted for review the abbreviated Biologics License Application (aBLA) for…

Biogen: FDA Accepts Application for Actemra Biosimilar >BIIB

Biogen: FDA Accepts Application for Actemra Biosimilar >BIIB...…

FDA Accepts Biogen Biologics License Application for BIIB800, A Biosimilar Candidate Referencing ACTEMRA® (tocilizumab)

CAMBRIDGE, Mass., Dec. 09, 2022 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) – announced that the U.S. Food…

Biogen, Eisai prompt Medicare to reevaluate Alzheimer’s coverage after new data

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Is Biogen (BIIB) Stock Undervalued Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to…

Zacks Investment Ideas feature highlights: ATAI Life Sciences, Biogen and Sage

ATAI Life Sciences, Biogen and Sage have been highlighted in this Investment Ideas article....…

Biogen (BIIB), Sage Finish Zuranolone NDA Filing for Depression

Biogen (BIIB) and Sage Therapeutics (SAGE) NDA submission for zuranolone for treating MDD and PPD is based on data from…

Why 2023 Could Be a Big Year for Biogen

Investors will soon learn if the companys Alzheimers treatment gets the green light....…

Shareholder Alert: Grabar Law Office Investigates Claims on Behalf of Shareholders of Biogen, Inc. (BIIB) After It Agrees to Pay $900 Million for Improper Kickbacks

Philadelphia, Pennsylvania--(Newsfile Corp. - December 7, 2022) - As announced by the DOJ, Biogen has agreed to pay $900…

Sage, Biogen complete rolling filing with FDA for depression therapy zuranolone

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Biogen: EMA to Review Tofersen in Rare Form of ALS >BIIB

Biogen: EMA to Review Tofersen in Rare Form of ALS >BIIB...…

Biogen: Kurszielerhöhung

London (www.aktiencheck.de) - Rating-Update: Steve Chesney, Analyst von Atlantic Equities, bewertet die Aktie von Biogen Inc. (ISIN: US09062X1037, WKN: 789617, Ticker-Symbol:…

Is Biogen Stock a Buy Now?

Its revenue now has a plausible path to doubling, but risks remain high....…

Biogen: Kursziel angehoben

London (www.aktiencheck.de) - Rating-Update: Carter Gould, Analyst von Barclays, stuft die Aktie von Biogen Inc. (ISIN: US09062X1037, WKN: 789617, Ticker-Symbol:…

Opening Bell: Salesforce, Snowflake, PVH, Biogen, Amazon, Netflix, Beyond Meat

FED-Chef Jerome Powell hat gestern eine langsamere Straffung der US-Zinspolitik angekündigt. Die US-Märkte reagierten mit einem kleinen Kursfeuerwerk darauf. Der…

Opening Bell: Dow Jones nach Vortagesrally erneut im Plus; Salesforce, Snowflake, PVH, Amazon, Netflix, Biogen im Fokus

Selbst enttäuschende Signale von Salesforce und Snowflake dürften am Donnerstag die Partylaune der Anleger im Technologiesektor zunächst kaum stören. Knapp…

Biogen: Neues Kursziel

Los Angeles (www.aktiencheck.de) - Rating-Update: Laura Chico, Analystin von Wedbush Securities, stuft die Aktie von Biogen Inc. (ISIN: US09062X1037, WKN:…

Biogen: Anlagevotum bestätigt

New York (www.aktiencheck.de) - Rating-Update: Salim Syed, Analyst von Mizuho Securities USA, stuft die Aktie von Biogen Inc. (ISIN: US09062X1037, WKN:…

Grabar Law Office Investigates Claims on Behalf of Shareholders of Biogen, Inc. (BIIB) After It Agrees to Pay $900 Million for Improper Physician Payments

Philadelphia, Pennsylvania--(Newsfile Corp. - November 30, 2022) - As announced by the DOJ, the settlement resolves a lawsuit filed and…

dpa-AFX ProFeed